Move easy
Osteoarthritis (OA) the second most common rheumatologic problem and it is the most frequent joint disease with a prevalence of 22% to 39% in India. The physical disability arising from pain and loss of functional capacity reduces quality of life…
Bone mineral density naturally declines after age 30, increasing susceptibility to fractures and osteoporosis. Over 50 million individuals in India are affected by low bone mass. While calcium is vital, its utilization depends heavily on adequate levels of Vitamin D3 and Vitamin K2…
Sarcopenia is the age-related loss of skeletal muscle mass, strength, and function. It occurs due to an imbalance between muscle protein synthesis and breakdown. This condition increases the risk of falls, fractures, disability, metabolic dysfunction, poor quality of life, and mortality…
Peripheral neuropathy is a nerve-damage condition affecting sensory, motor, or autonomic pathways. It impacts approximately 2.4% of the global population, with prevalence increasing to nearly 7% in adults over 45. Common symptoms include pain, tingling, numbness, muscle weakness, and reduced reflexes.
Osteoarthritis (OA) the second most common rheumatological problem and it is the most frequent joint disease with a prevalence of 22% to 39% in India. The physical disability arising from pain and loss of functional capacity reduces quality of life and increases the risk of further morbidity.
Medical management of OA includes weight reduction, physiotherapy, and pharmacotherapy. These have only modest benefits and aim at reducing pain, improving joint mobility and quality of life. Surgical intervention in the form of replacement surgeries are usually the last resort.
The first line treatment in early stages includes weight reduction, use of ambulatory aids, intra-articular steroid injections and non-steroidal anti-inflammatory drugs (NSAIDs). Abuse of NSAIDs is common and can cause gastrointestinal toxicity in 50% of the users, while 5.4% develop a more serious event like cardiovascular diseases requiring hospitalization.
Hence there is a need for a natural solution for management of OA which is effective and safe.
BLM OsteoVida contains avocado and soybean unsaponifiables (ASU), made from fruits and seeds of avocado and soybean oil. Characterized by its potent anti-inflammatory effects, this ASU mixture is recommended to act as an adjuvant treatment for osteoarthritic pain and slow-acting symptomatic treatment of hip and knee osteoarthritis. AVOVIDA is a branded proprietary ASU ingredient which has been clinically tried in Europe and USA.
PROTECT, BUILD & REPAIR
Osteoarthritis
Bone mineral density naturally declines after age 30, increasing susceptibility to fractures and osteoporosis. Over 50 million individuals in India are affected by low bone mass. While calcium is vital, its utilization depends heavily on adequate levels of Vitamin D3 and Vitamin K2, both of which are frequently deficient.
BLM Vitalis delivers a scientifically designed soft chewable capsule containing vegan Vitamin D3 (UK-sourced) and natural Vitamin K2-7 (Japan-sourced). This powerful duo enhances calcium absorption, strengthens bone mineralization, and supports vascular well-being. It is India’s first 100% vegetarian soft chew capsule with a pleasant orange flavor for better daily adherence.
Convenient and palatable format of Vitamin D3 + K2 for bone health
Overall bone health
Sarcopenia is the age-related loss of skeletal muscle mass, strength, and function. It occurs due to an imbalance between muscle protein synthesis and breakdown. This condition increases the risk of falls, fractures, disability, metabolic dysfunction, poor quality of life, and mortality. In India, sarcopenia affects nearly 20–30% of older adults above 60, and currently, there are no approved pharmacological treatments, making nutrition and exercise the most effective management strategies.
BLM MyoActiv is a triple-action, clinically supported formulation designed to preserve muscle strength, enhance physical function, and combat age-related muscle loss. It combines myHMB®, a patented and clinically studied form of β-hydroxy β-methylbutyrate (HMB); Lactobacillus plantarum TWK10, a clinically studied probiotic known for its benefits on exercise performance and muscle health; and Vitamin D3, which is essential for muscle function and bone health.
A first-of-its-kind triple-action formulation for sarcopenia
Sarcopenia
